​

Funding Round

Seed Round - Nvelop Therapeutics

Seed Round - Nvelop Therapeutics

Investment Firm

Overview

Nvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs.

Announced Date

Sep 25, 2023

Funding Type

Seed

Highlights

Location

United States, North America

Social

Investor Lead

Newpath Management

Newpath Management

Newpath Management is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorNewpath Management
Participant Investor5AM Ventures
Participant InvestorF-Prime Capital
Participant InvestorAtlas Venture

Round Details and Background

Nvelop Therapeutics raised $100000000 on 2023-09-25 in Seed Round

Nvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 25, 2023
Seed Round - Nvelop Therapeutics
4-100.0M

Recent Activity

There is no recent news or activity for this profile.